Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Research Highlight
  • Published:

Cannabinoid 1 receptor blockade to treat obesity and cardiovascular risk factors

This article has been updated

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Change history

  • 17 May 2018

    This article was published with the same DOI as a previous publication. A new DOI has been assigned and registered at Crossref, and has been corrected in the article.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cannabinoid 1 receptor blockade to treat obesity and cardiovascular risk factors. Nat Rev Gastroenterol Hepatol 2, 252–253 (2005). https://doi.org/10.1038/ncpcardio0207x

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpcardio0207x

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing